102 related articles for article (PubMed ID: 7923932)
41. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
42. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
Paul ME; Shearer WT; Kozinetz CA; Lewis DE
J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
[TBL] [Abstract][Full Text] [Related]
43. A raised level of soluble CD8 in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis in Japan.
Hamagami S; Miyagawa T; Ochi T; Tsuyuguchi I; Kishimoto S
Chest; 1992 Apr; 101(4):1044-9. PubMed ID: 1555419
[TBL] [Abstract][Full Text] [Related]
44. Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals.
Levin A; Brubaker G; Shao JS; Kumby D; O'Brien TR; Goedert JJ; Strauss KW; Blattner WA; Hannet I
Int J STD AIDS; 1996 Jul; 7(4):288-91. PubMed ID: 8876362
[TBL] [Abstract][Full Text] [Related]
45. Viro-immunological studies in acute HIV-1 infection.
Roos MT; de Leeuw NA; Claessen FA; Huisman HG; Kootstra NA; Meyaard L; Schellekens PT; Schuitemaker H; Miedema F
AIDS; 1994 Nov; 8(11):1533-8. PubMed ID: 7848590
[TBL] [Abstract][Full Text] [Related]
46. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
[TBL] [Abstract][Full Text] [Related]
47. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
48. Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.
Simon HU; Yousefi S; Dommann-Scherrer CC; Zimmermann DR; Bauer S; Barandun J; Blaser K
J Exp Med; 1996 Mar; 183(3):1071-82. PubMed ID: 8642249
[TBL] [Abstract][Full Text] [Related]
49. Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.
Janossy G; Borthwick N; Lomnitzer R; Medina E; Squire SB; Phillips AN; Lipman M; Johnson MA; Lee C; Bofill M
AIDS; 1993 May; 7(5):613-24. PubMed ID: 8318170
[TBL] [Abstract][Full Text] [Related]
50. Blood transfusions with high levels of contaminating soluble HLA-I correlate with levels of soluble CD8 in recipients' plasma; a new control factor in soluble HLA-I-mediated transfusion-modulated immunomodulation?
Ghio M; Contini P; Ubezio G; Ansaldi F; Setti M; Tripodi G
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s105-8. PubMed ID: 23356971
[TBL] [Abstract][Full Text] [Related]
51. CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.
Pantaleo G; De Maria A; Koenig S; Butini L; Moss B; Baseler M; Lane HC; Fauci AS
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4818-22. PubMed ID: 2112749
[TBL] [Abstract][Full Text] [Related]
52. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O; Holub M; Spála J; Kalanin J; Stanková M
Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
[TBL] [Abstract][Full Text] [Related]
53. [Characteristics of immunophenotypic alterations in 263 HIV/AIDS patients].
Xie J; Qiu ZF; Li TS; Han Y; Zuo LY; Ma XJ; Liu ZY; Wang AX
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):965-9. PubMed ID: 16759536
[TBL] [Abstract][Full Text] [Related]
54. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
Phillips AN; Sabin CA; Elford J; Bofill M; Lee CA; Janossy G
AIDS; 1993 Jul; 7(7):975-80. PubMed ID: 8102854
[TBL] [Abstract][Full Text] [Related]
55. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
56. [Soluble lymphocyte antigens in hematological diseases].
Yoneyama A; Higashihara M; Nakahara K
Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
[TBL] [Abstract][Full Text] [Related]
57. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analysis of CD6, CD4 and CD8 cell surface molecules compared to the absolute numbers of CD6+, CD4+ and CD8+ T-cells in peripheral blood in patients with HIV-infection.
Gruber R; Endl J; Fröschl M; Rieber EP; Ziegler-Heitbrock HW; Riethmüller G
J Clin Lab Immunol; 1991 Aug; 35(4):157-63. PubMed ID: 1668851
[TBL] [Abstract][Full Text] [Related]
59. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
[TBL] [Abstract][Full Text] [Related]
60. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
Starr SE; Sarr M; Campbell DE; Wilson CM; Douglas SD
AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1301-10. PubMed ID: 12487818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
